Product Information
TETRABENAZINE 25 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.3363 per EA under NDC 31722082211. Its NADAC has been published 142 times since Jan 17, 2024.
FDA first approved this application on Feb 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722082211
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TETRABENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA204574FDA Approved
2/3/2016
TE Code
AB
On Market Since
8/17/2015
Pharmacological Classes
Price Statistics
The NADAC for TETRABENAZINE 25 MG TABLET has been published 142 times since Jan 17, 2024, and over the history we have for it it has declined 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3363 per EA |
|---|---|
| All-time high | $1.6207 (Apr 16, 2025) |
| All-time low | $1.1286 (Aug 21, 2024) |
| 52-week high | $1.3500 |
| 52-week low | $1.2014 |
| Median price | $1.3380 |
| Average price | $1.3720 |
| Largest weekly change | +29.3% (Nov 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tetrabenazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vesicular Monoamine Transporter 2 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TETRABENAZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 25 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.3363 per EA (NDC 31722082211), effective Sep 30, 2026.
How has the price of TETRABENAZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for TETRABENAZINE 25 MG TABLET has declined 10.8%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for TETRABENAZINE 25 MG TABLET?
Since Jan 17, 2024, the NADAC for TETRABENAZINE 25 MG TABLET has ranged from a low of $1.1286 (Aug 21, 2024) to a high of $1.6207 (Apr 16, 2025), with a median of $1.3380 per EA.
Are there cheaper alternatives to TETRABENAZINE 25 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TETRABENAZINE 25 MG TABLET, is $1.2044 per EA — about 10% below TETRABENAZINE 25 MG TABLET.
Who manufactures TETRABENAZINE 25 MG TABLET?
TETRABENAZINE 25 MG TABLET (NDC 31722082211) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.